Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
The report details the trend, potential and market size of Long Acting Insulins market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Long Acting Insulinsmarket, defines the market attractiveness level of Long Acting Insulins market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Long Acting Insulins industry, describes the types of Long Acting Insulins market, the applications of major players and the market size, and deeply analyzes the current situation of the global Long Acting Insulins market and the development prospects and opportunities of Long Acting Insulins industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Long Acting Insulins market in Chapter 13.
By Player:
Novo Nordisk A/S
Sanofi SA
Biocon Limited
Pfizer Inc
Eli Lilly and Company
By Type:
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin
By End-User:
Home Use
Medical Institutions
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Long Acting Insulins Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Long Acting Insulins Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Long Acting Insulins Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Long Acting Insulins Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Long Acting Insulins Market Analysis and Outlook to 2022
-
7.1 Global Long Acting Insulins Consumption (2017-2022)
-
7.2 United States Long Acting Insulins Consumption (2017-2022)
-
7.3 Europe Long Acting Insulins Consumption (2017-2022)
-
7.4 China Long Acting Insulins Consumption (2017-2022)
-
7.5 Japan Long Acting Insulins Consumption (2017-2022)
-
7.6 India Long Acting Insulins Consumption (2017-2022)
-
7.7 South Korea Long Acting Insulins Consumption (2017-2022)
8 Region and Country-wise Long Acting Insulins Market Analysis and Outlook to 2028
-
8.1 Global Long Acting Insulins Consumption Forecast (2022-2028)
-
8.2 United States Long Acting Insulins Consumption Forecast (2022-2028)
-
8.3 Europe Long Acting Insulins Consumption Forecast (2022-2028)
-
8.4 China Long Acting Insulins Consumption Forecast (2022-2028)
-
8.5 Japan Long Acting Insulins Consumption Forecast (2022-2028)
-
8.6 India Long Acting Insulins Consumption Forecast (2022-2028)
-
8.7 South Korea Long Acting Insulins Consumption Forecast (2022-2028)
9 Global Long Acting Insulins Market Outlook by Types and Applications to 2022
-
9.1 Global Long Acting Insulins Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Insulin Glargine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Insulin Determir Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Insulin Degludec Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Long Acting Animal Insulin Consumption and Growth Rate (2017-2022)
-
9.2 Global Long Acting Insulins Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Home Use Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medical Institutions Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Long Acting Insulins Market Outlook by Types and Applications to 2028
-
10.1 Global Long Acting Insulins Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Insulin Glargine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Insulin Determir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Insulin Degludec Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Long Acting Animal Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Long Acting Insulins Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Home Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medical Institutions Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Long Acting Insulins Import and Export Analysis (Top 5 Countries)
-
11.1 Global Long Acting Insulins Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Long Acting Insulins Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Long Acting Insulins Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Long Acting Insulins Market Competitive Analysis
-
14.1 Novo Nordisk A/S
-
14.1.1 Novo Nordisk A/S Company Details
-
14.1.2 Novo Nordisk A/S Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novo Nordisk A/S Long Acting Insulins Product and Service
-
14.2 Sanofi SA
-
14.2.1 Sanofi SA Company Details
-
14.2.2 Sanofi SA Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi SA Long Acting Insulins Product and Service
-
14.3 Biocon Limited
-
14.3.1 Biocon Limited Company Details
-
14.3.2 Biocon Limited Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biocon Limited Long Acting Insulins Product and Service
-
14.4 Pfizer Inc
-
14.4.1 Pfizer Inc Company Details
-
14.4.2 Pfizer Inc Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Inc Long Acting Insulins Product and Service
-
14.5 Eli Lilly and Company
-
14.5.1 Eli Lilly and Company Company Details
-
14.5.2 Eli Lilly and Company Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eli Lilly and Company Long Acting Insulins Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Long Acting Insulins
-
Figure Long Acting Insulins Picture
-
Table Global Long Acting Insulins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Long Acting Insulins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Long Acting Insulins Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Long Acting Insulins Consumption by Country (2017-2022)
-
Figure United States Long Acting Insulins Consumption and Growth Rate (2017-2022)
-
Table Europe Long Acting Insulins Consumption and Growth Rate (2017-2022)
-
Figure China Long Acting Insulins Consumption and Growth Rate (2017-2022)
-
Figure Japan Long Acting Insulins Consumption and Growth Rate (2017-2022)
-
Figure India Long Acting Insulins Consumption and Growth Rate (2017-2022)
-
Figure South Korea Long Acting Insulins Consumption and Growth Rate (2017-2022)
-
Figure Global Long Acting Insulins Consumption Forecast by Country (2022-2028)
-
Figure United States Long Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Long Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Long Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Long Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Long Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Long Acting Insulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Glargine Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Determir Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Degludec Consumption and Growth Rate (2017-2022)
-
Figure Global Long Acting Animal Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Home Use Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Institutions Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Glargine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Determir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Degludec Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long Acting Animal Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Institutions Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Long Acting Insulins Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Long Acting Insulins Export by Region (Top 5 Countries) (2017-2028)
-
Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk A/S Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk A/S Long Acting Insulins Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Long Acting Insulins Product and Service
-
Table Biocon Limited (Foundation Year, Company Profile and etc.)
-
Table Biocon Limited Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Limited Long Acting Insulins Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Long Acting Insulins Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Long Acting Insulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Long Acting Insulins Product and Service
-
